Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Science Signaling|August 31, 2017
Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signalingShunsuke Uehara, Nobuyuki Udagawa, Hideyuki Mukai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[A Case Report of Conversion Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastasis after Chemotherapy]Yoshiteru Katsura, Yutaka Takeda, Yoshiaki Ohmura, et al.
Veterinary Immunology and Immunopathology|November 3, 2022
Expression profile of immunoregulatory factors in canine tumorsKohei Murakami, Saki Miyatake, Jiro Miyamae, et al.
Esophagus : Official Journal of the Japan Esophageal Society|March 27, 2026
How I do it: The Hi-UP approach-single-port da Vinci SP-assisted mediastinoscopic subtotal esophagectomy with a transhiatal-dominant strategy in the abdominal and cervical phasesTakeshi Omori, Tomoki Makino, Yujiro Nakahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[A Case of Rectal Cancer with Multiple Endocrine Neoplasia Type 2]Ryota Mori, Kohei Murata, Yoshinori Kagawa, et al.
Surgery Today|April 28, 2024
Prognostic factors and significance of postoperative adjuvant chemotherapy in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy followed by gastrectomyMasaaki Motoori, Kentaro Kishi, Kazuyoshi Yamamoto, et al.
Scientific Reports|August 15, 2020
Sclerostin expression in trabecular bone is downregulated by osteoclastsMasanori Koide, Teruhito Yamashita, Kohei Murakami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Experience of Treatment with Lenvatinib in Patients with Advanced HCC-A in a Single Institution]Yoshiteru Katsura, Yutaka Takeda, Yoshiaki Ohmura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[A Case of Leiomyosarcoma of the Sigmoidal Mesocolon]Koki Takase, Kohei Murata, Atsushi Naito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[A Case of Stage IV Metaplastic Breast Cancer in Which Primary Tumor Was Removed after Treatment with Anti-HER2 Systemic Therapy]Chiyomi Egawa, Junichi Inatome, Takuya Sakamoto, et al.
Pageof 14